214 related articles for article (PubMed ID: 38526755)
1. Proceedings of the 2024 North American Society of Head and Neck Pathology Companion Meeting, Baltimore, MD, March 24, 2024: Navigating Ancillary Studies in Basaloid/Blue Salivary Tumors.
Wong KS
Head Neck Pathol; 2024 Mar; 18(1):24. PubMed ID: 38526755
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
Foo WC; Jo VY; Krane JF
Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
[TBL] [Abstract][Full Text] [Related]
3. PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.
Avadhani V; Cohen C; Siddiqui MT
Acta Cytol; 2016; 60(3):240-5. PubMed ID: 27463119
[TBL] [Abstract][Full Text] [Related]
4. Don't SUMP it! Utility of PLAG1 immunocytochemistry in basaloid SUMP subcategory.
Sanchez-Avila M; Tjendra Y; Zuo Y; Ruiz-Cordero R; Garcia-Buitrago M; Jorda M; Gomez-Fernandez C; Velez Torres JM
Cancer Cytopathol; 2024 Jan; 132(1):60-68. PubMed ID: 37702124
[TBL] [Abstract][Full Text] [Related]
5. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
6. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
[TBL] [Abstract][Full Text] [Related]
7. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.
Matsuyama A; Hisaoka M; Nagao Y; Hashimoto H
Virchows Arch; 2011 May; 458(5):583-92. PubMed ID: 21394649
[TBL] [Abstract][Full Text] [Related]
8. Updated Salivary Gland Immunohistochemistry: A Review.
Swid MA; Li L; Drahnak EM; Idom H; Quinones W
Arch Pathol Lab Med; 2023 Dec; 147(12):1383-1389. PubMed ID: 37074867
[TBL] [Abstract][Full Text] [Related]
9. Basaloid/blue salivary gland tumors.
Seethala RR
Mod Pathol; 2017 Jan; 30(s1):S84-S95. PubMed ID: 28060371
[TBL] [Abstract][Full Text] [Related]
10. Fine-Needle Aspiration Cytology of Cellular Basaloid Neoplasms of the Salivary Gland.
Cantley RL
Arch Pathol Lab Med; 2019 Nov; 143(11):1338-1345. PubMed ID: 31509452
[TBL] [Abstract][Full Text] [Related]
11. PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland.
Matsuyama A; Hisaoka M; Hashimoto H
Pathol Int; 2012 Jan; 62(1):1-7. PubMed ID: 22192798
[TBL] [Abstract][Full Text] [Related]
12. PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study.
Matsuyama A; Hisaoka M; Hashimoto H
Virchows Arch; 2011 Nov; 459(5):539-45. PubMed ID: 21927843
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.
El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S
Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520
[TBL] [Abstract][Full Text] [Related]
14. Assessing the diagnostic accuracy for pleomorphic adenoma and Warthin tumor by employing the Milan System for Reporting Salivary Gland Cytopathology: An international, multi-institutional study.
Allison DB; Smith AP; An D; Miller JA; Shafique K; Song S; Viswanathan K; Eykman E; Rao RA; Wiles A; Barkan GA; Nayar R; Fadda G; Powers CN; Rossi ED; Siddiqui MT; Ali SZ; Kholová I; Layfield LJ; Field A; Baloch Z; Maleki Z
Cancer Cytopathol; 2021 Jan; 129(1):43-52. PubMed ID: 32767837
[TBL] [Abstract][Full Text] [Related]
15. SOX10 Immunoexpression in Basaloid Squamous Cell Carcinomas: A Diagnostic Pitfall for Ruling out Salivary Differentiation.
Rooper LM; McCuiston AM; Westra WH; Bishop JA
Head Neck Pathol; 2019 Dec; 13(4):543-547. PubMed ID: 30498968
[TBL] [Abstract][Full Text] [Related]
16. Basaloid tumors of the salivary glands.
Chhieng DC; Paulino AF
Ann Diagn Pathol; 2002 Dec; 6(6):364-72. PubMed ID: 12478487
[TBL] [Abstract][Full Text] [Related]
17. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
[TBL] [Abstract][Full Text] [Related]
18. Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors.
Bubola J; MacMillan CM; Demicco EG; Chami RA; Chung CT; Leong I; Marrano P; Onkal Z; Swanson D; Veremis BM; Weinreb I; Zhang L; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2021 Oct; 60(10):695-708. PubMed ID: 34176176
[TBL] [Abstract][Full Text] [Related]
19. Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice.
Zhao X; Ren W; Yang W; Wang Y; Kong H; Wang L; Yan L; Xu G; Fei J; Fu J; Zhang C; Wang Z
Int J Cancer; 2006 Feb; 118(3):643-8. PubMed ID: 16108035
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
Toper MH; Sarioglu S
Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
